Search by Drug Name or NDC
NDC 69117-0003-04 Anastrozole 1 mg/1 Details
Anastrozole 1 mg/1
Anastrozole is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Yiling Pharmaceutical, Inc.. The primary component is ANASTROZOLE.
MedlinePlus Drug Summary
Anastrozole is used with other treatments, such as surgery or radiation, to treat early breast cancer in women who have experienced menopause (change of life; end of monthly menstrual periods). This medication is also used in women, who have experienced menopause, as a first treatment of breast cancer that has spread within the breast or to other areas of the body. This medication is also used to treat breast cancer in women whose breast cancer has worsened after taking tamoxifen (Nolvadex). Anastrozole is in a class of medications called nonsteroidal aromatase inhibitors. It works by decreasing the amount of estrogen the body makes. This can slow or stop the growth of many types of breast cancer cells that need estrogen to grow.
Related Packages: 69117-0003-04Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Anastrozole
Product Information
| NDC | 69117-0003 |
|---|---|
| Product ID | 69117-0003_0da71c65-aad3-6d6c-e063-6394a90a64eb |
| Associated GPIs | 21402810000310 |
| GCN Sequence Number | 024515 |
| GCN Sequence Number Description | anastrozole TABLET 1 MG ORAL |
| HIC3 | V3F |
| HIC3 Description | ANTINEOPLASTIC - AROMATASE INHIBITORS |
| GCN | 24410 |
| HICL Sequence Number | 010249 |
| HICL Sequence Number Description | ANASTROZOLE |
| Brand/Generic | Generic |
| Proprietary Name | Anastrozole |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Anastrozole Tablets |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 1 |
| Active Ingredient Units | mg/1 |
| Substance Name | ANASTROZOLE |
| Labeler Name | Yiling Pharmaceutical, Inc. |
| Pharmaceutical Class | Aromatase Inhibitor [EPC], Aromatase Inhibitors [MoA] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA206037 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 69117-0003-04 (69117000304)
| NDC Package Code | 69117-0003-4 |
|---|---|
| Billing NDC | 69117000304 |
| Package | 1000 TABLET in 1 BOTTLE (69117-0003-4) |
| Marketing Start Date | 2019-02-28 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |